Cutler Group LP Corcept Therapeutics Inc Call Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$17.33 - $25.3 $15,596 - $22,770	-900 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$16.53 - $25.21 $14,877 - $22,689	900 New	900 $0
Q4 2020 Jan 21, 2021	SELL	$16.78 - $27.3 $72,154 - $117,390	-4,300 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$12.46 - $19.98 $53,578 - $85,914	4,300 New	4,300 $10,000
Q1 2019 May 10, 2019	SELL	$10.03 - $15.71 $30,089 - $47,130	-3,000 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$11.29 - $17.19 $33,870 - $51,570	3,000 New	3,000 $2,000
Q3 2018 Nov 07, 2018	SELL	$12.27 - $15.65 $62,577 - $79,815	-5,100 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$15.3 - $19.69 $68,850 - $88,605	4,500 Added 750.0%	5,100 $2,000
Q1 2018 May 11, 2018	BUY	$14.59 - $25.5 $7,295 - $12,750	500 Added 500.0%	600 $0
Q4 2017 Jan 17, 2018	SELL	$15.77 - $20.72 $20,501 - $26,936	-1,300 Reduced 92.86%	100 $0
Q3 2017 Oct 17, 2017	BUY	$12.3 - $19.3 $17,220 - $27,020	1,400	1,400 $10,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.